Contributors
|
D G Altman
ICRF Medical Statistics Group, UK |
|
C Anello
Rockville, USA |
V C Arena
University of Pittsburgh, USA |
D Ashby
St Bartholomews & Royal School of Medicine, UK |
J Baron
Dartmouth Medical School, USA |
C Begg
Memorial Sloan Kettering Cancer Center, USA |
W C Blackwelder
Bethesda, USA |
J L Bryant
NSABP, Pittsburgh, USA |
M Buyse
International Institute for Drug Development, Belgium |
I Chalmers
UK Cochrane Centre, UK |
J F Collins
Veterans Affairs Medical Center, Perry Point, USA |
J P Costantino
University of Pittsburgh, USA |
W Cronin
NSABP, Pittsburgh, USA |
C E Davis
University of North Carolina, USA |
S J Day
Leo Laboratories, UK |
V de Gruttola
Harvard School of Public Health, USA |
D L DeMets
University of Wisconsin, USA |
D O Dixon
National Institute of Health, USA |
A Donner
University of Western Ontario, Canada |
F Ederer
The EMMES Corporation, USA |
J Ellenberg
Westat, USA |
S Evans
Medicines Control Agency, UK |
K Facey
Health Technology Board for Scotland, UK |
J R Feussner
VA Cooperative Studies Program, USA |
B Fisher
NSABP, Pittsburgh, USA |
L D Fisher
University of Washington, USA |
T R Fleming
University of Washington, USA |
M Foulkes
FDA CBER, USA |
R G Frank
Harvard Medical School, USA |
S Freels
University of Illinois at Chicago, USA |
L M Friedman
Rockledge Center, USA |
E A Gehan
Georgetown University Medical Center, USA |
N Geller
National Institute of Health, USA |
S George
Duke University Medical Center, USA |
M J Godley
Zeneca Pharmaceuticals, UK |
S B Green
Case Western Reserve University, USA |
E Halloran
Emory University, USA |
W G Henderson
Veterans Affairs Medical Center, Hines, USA |
C H Hennekens
Harvard University, USA |
J Heyse
Merck and Co., Inc., USA |
M D Hughes
London School of Hygiene & Tropical Medicine, UK |
J Hutton
University of Warwick, UK |
D R Jones
University of Leicester, UK |
N Klar
Cancer Care Ontario, Canada |
G Knatterud
Maryland Medical Research Institute, USA |
T Koepsell
University of Washington, USA |
E Lakatos
Forest Laboratories, New York, USA |
J R Lave
University of Pittsburgh, USA |
P W Lavori
Stanford University, USA |
J Lewis
Medicines Control Agency, UK |
J Massaro
Quintiles Inc, USA |
E McFadden
ECOG Coordinating Center, USA |
P Meier
Columbia University, USA |
C Meinert
John Hopkins School of Hygiene and Public Health, USA |
R Mick
University of Pennsylvania, USA |
D Moher
University of Ottowa, Canada |
B J Morgan
University of Kent at Canterbury, UK |
D D V Morgan
Hoechst Marion Roussel, UK |
G D Murray
University of Edinburgh, UK |
P C O'Brien
Mayo Clinic, USA |
P Peduzzi
Veterans Affairs Medical Center, West Haven, USA |
S Piantadosi
Johns Hopkins University, USA |
R L Prentice
Fred Hutchinson Cancer Center, USA |
P C Prorok
National Cancer Institute, USA |
H Rockette
University of Pittsburgh, USA |
L V Rubinstein
National Instutue of Health, USA |
L M Ryan
Harvard School of Public Health, USA |
D L Sackett
University of Oxford, UK |
M R Sather
Veterans Affairs Medical Center, Albuquerque, USA |
M Schneiderman
deceased April 1996, |
S Senn
University College London, UK |
S Silagy
Australasian Cochrane Centre, Australia |
R Simon
National Institute of Health, USA |
P Skerrett
Harvard Medical School, USA |
C Smith
Zeneca Pharmaceuticals, UK |
K Soper
Merck and Co., Inc., USA |
B E Storer
Fred Hutchinson Cancer Center, USA |
I Sutherland
Cambridge, UK |
R J Sylvester
EORTC Data Center, Belgium |
P F Thall
M D Anderson Cancer Center, USA |
S G Thompson
MRC Biostatistics Unit, UK |
R S Ungerleider
Cancer Therapy Evaluation Program, USA |
J Ware
Harvard School of Public Health, USA |
L Weissfeld
University of Pittsburgh, USA |
J Whitehead
University of Reading, UK |
H S Wieand
University of Pittsburgh, USA |
J Wittes
Statistics Collaborative, USA |
S Zeger
John Hopkins University, USA |